Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Singapore Cord Blood Bank is Singapore's first and only public community cord blood bank, operating as a non-profit organization focused on collecting, processing, banking and distributing umbilical cord blood units for transplantation. The organization provides both public donation and family banking services, with stored units used for unrelated allogeneic haematopoietic stem cell transplants and approved clinical uses. Its inventory is geared toward serving ethnically diverse Asian populations and is listed on international registries to support transplant searches worldwide. SCBB is internationally accredited and collaborates with maternity hospitals across Singapore for cord blood collection. For a biotech or healthcare analyst, SCBB is best understood as a healthcare infrastructure and cellular therapy-enabling organization rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Singapore Cord Blood Bank.